How the clinic describes access and care.
This section brings together published information about location, care setting, costs, services, and organization.
Visiting & getting started
- Location
- Denver, United States
- Care setting
- Inpatient, Outpatient
- Languages
- English
- Referral information
- CAR T-cell programs use specialist referral and diagnosis-specific intake pathways.
Costs & coverage
- Published costs
- Contact the center for current access, coverage and financial-coordination information.
- Insurance
- Coverage and authorization are coordinated for the specific CAR T-cell product and treatment pathway.
Clinical & organizational information
- Practitioners / credentials
- The center assigns a disease-specific hematology and cellular-therapy team through its referral process.
- Cancer specialties
- Blood cancers, Lymphoma, Leukemia, Multiple myeloma
- Patient populations
- Adults
- Clinical trials
- Contact the cellular-therapy program for current study and referral information.
What to know about this center.
Center, location and care setting
The Colorado Blood Cancer Institute (cbci), A Part Of Sarah Cannon Cancer Institute At Presbyterian/st Luke’s Medical Center is listed in Denver, Colorado and United States. Its recorded care setting is hospital. The directory classifies its published care areas as conventional oncology and cellular therapy.
Treatments and services connected to this profile
Cancer Clinic Finder research currently connects The Colorado Blood Cancer Institute (cbci), A Part Of Sarah Cannon Cancer Institute At Presbyterian/st Luke’s Medical Center with CAR T-cell therapy. Open the linked treatment guides from this profile and confirm the current program, treating department and appointment location when scheduling.
Referral and first appointment
CAR T-cell programs use specialist referral and diagnosis-specific intake pathways. Patients can also confirm which medical records, pathology, imaging and prior treatment details should arrive before the visit.
Insurance and cost planning
Coverage and authorization are coordinated for the specific CAR T-cell product and treatment pathway. Contact the center for current access, coverage and financial-coordination information.
Clinical trials and research access
Contact the cellular-therapy program for current study and referral information. Trial screening is performed by the relevant program after the diagnosis, prior treatment and required records are reviewed.
Travel and visit planning
People traveling to Denver, Colorado and United States can ask how long the evaluation may take, whether appointments can be grouped, and which treatment or follow-up visits may be coordinated with clinicians closer to home. The profile lists the center at 1721 E 19th Ave,Denver,CO 80218.
Reported treatments & supportive services
These connections come from Cancer Clinic Finder research, clinic-confirmed selections, or both. Open a guide to learn more and discover other clinics reporting the same approach.
Cancer guides related to reported specialties
These guides connect to cancer specialties named in this clinic’s cited materials.
Sources
Source information checked: 2026-10-05. The links below identify the public and clinic-provided materials used for this page.
Compiled by: Cancer Clinic Finder Editorial Team
- Official Yescarta authorized treatment-center record — THE COLORADO BLOOD CANCER INSTITUTE (CBCI), A PART OF SARAH CANNON CANCER INSTITUTE AT PRESBYTERIAN/ST LUKE’S MEDICAL CENTER ↗Checked 2026-10-04
- Official The Colorado Blood Cancer Institute (cbci), A Part Of Sarah Cannon Cancer Institute At Presbyterian/st Luke’s Medical Center program or hospital page ↗Checked 2026-10-04
How Cancer Clinic Finder compiles information · Suggest a factual correction
